Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Rating of “Buy” from Analysts
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has been assigned an average recommendation of “Buy” from the six analysts that are covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have issued a report on the stock in the […]
More Stories
Jeffrey Epstein Guard Called to Testify Before House Oversight Committee
By Jacki Thrapp One of the guards on duty when Jeffrey Epstein died in his cell will testify before the...
Senate Floor Fight Reveals How Far Apart Democrats and Republicans Are on DHS Shutdown
By Chase Smith For two days this week, senators took turns proposing ways to end the partial shutdown of the...
US Mortgage Rates Jump to 6.11 Percent
By Naveen Athrappully Mortgage rates have risen for the second consecutive week, moving up to 6.11 percent after briefly dipping...
US Sending More Marines, Warships to Middle East
By Ryan Morgan ARLINGTON, Va.—A U.S. Marine Expeditionary Unit is set to reposition to the Middle East amid ongoing military...
How the US Can Adjust to Middle East Oil Disruptions
By Kevin Stocklin The U.S.–Israeli war with Iran has brought heightened volatility to energy and equity markets, with the price...
Shooting For Ginny & Georgia Season 4 Has Ended: Release Date and Cast Updates
The Netflix American drama Ginny & Georgia, which premiered on Netflix on February 24, 2021, has received huge appreciation and...